These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 21056937)
1. Lacosamide neurotoxicity associated with concomitant use of sodium channel-blocking antiepileptic drugs: a pharmacodynamic interaction? Novy J; Patsalos PN; Sander JW; Sisodiya SM Epilepsy Behav; 2011 Jan; 20(1):20-3. PubMed ID: 21056937 [TBL] [Abstract][Full Text] [Related]
2. A pooled analysis of lacosamide clinical trial data grouped by mechanism of action of concomitant antiepileptic drugs. Sake JK; Hebert D; Isojärvi J; Doty P; De Backer M; Davies K; Eggert-Formella A; Zackheim J CNS Drugs; 2010 Dec; 24(12):1055-68. PubMed ID: 21090839 [TBL] [Abstract][Full Text] [Related]
3. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine. Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245 [TBL] [Abstract][Full Text] [Related]
4. Minimizing pharmacodynamic interactions of high doses of lacosamide. Edwards HB; Cole AG; Griffiths AS; Lin B; Bean A; Krauss GL Acta Neurol Scand; 2012 Apr; 125(4):228-33. PubMed ID: 22070525 [TBL] [Abstract][Full Text] [Related]
5. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits. Stephen LJ; Wishart A; Brodie MJ Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500 [TBL] [Abstract][Full Text] [Related]
6. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation. Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147 [TBL] [Abstract][Full Text] [Related]
7. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial. Halász P; Kälviäinen R; Mazurkiewicz-Beldzińska M; Rosenow F; Doty P; Hebert D; Sullivan T; Epilepsia; 2009 Mar; 50(3):443-53. PubMed ID: 19183227 [TBL] [Abstract][Full Text] [Related]
8. Clinical experience with using lacosamide for the treatment of epilepsy in a tertiary centre. Kamel JT; DeGruyter MA; D'Souza WJ; Cook MJ Acta Neurol Scand; 2013 Mar; 127(3):149-53. PubMed ID: 22845761 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic Monitoring of Lacosamide in Japanese Patients With Epilepsy: Clinical Response, Tolerability, and Optimal Therapeutic Range. Yamamoto Y; Terada K; Araki Y; Fukushima Y; Imai K; Kagawa Y; Takahashi Y Ther Drug Monit; 2020 Oct; 42(5):754-759. PubMed ID: 32941398 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate. Patsalos PN; Berry DJ Expert Opin Pharmacother; 2012 Apr; 13(5):699-715. PubMed ID: 22404663 [TBL] [Abstract][Full Text] [Related]
12. Preliminary efficacy and safety of lacosamide in children with refractory epilepsy. Heyman E; Lahat E; Levin N; Berkovitch M; Gandelman-Marton R Eur J Paediatr Neurol; 2012 Jan; 16(1):15-9. PubMed ID: 21924653 [TBL] [Abstract][Full Text] [Related]
13. Lacosamide intoxication in attempted suicide. Bauer S; David Rudd G; Mylius V; Hamer HM; Rosenow F Epilepsy Behav; 2010 Apr; 17(4):549-51. PubMed ID: 20171144 [TBL] [Abstract][Full Text] [Related]
14. Lacosamide and concomitant use of antiepileptic and other medications in a US population - A retrospective cohort study. Kalilani L; Lu C; Pierre-Louis B; Gold M Epilepsy Behav; 2017 Jul; 72():51-57. PubMed ID: 28575767 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of lacosamide in the concomitant treatment of 130 patients under 16 years of age with refractory epilepsy: a prospective, open-label, observational, multicenter study in Spain. Casas-Fernández C; Martínez-Bermejo A; Rufo-Campos M; Smeyers-Durá P; Herranz-Fernández JL; Ibáñez-Micó S; Campistol-Plana J; Alarcón-Martínez H; Campos-Castelló J Drugs R D; 2012 Dec; 12(4):187-97. PubMed ID: 23193979 [TBL] [Abstract][Full Text] [Related]
16. Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs. Foldvary-Schaefer N; Fong JS; Morrison S; Wang L; Bena J Epilepsy Behav; 2016 Apr; 57(Pt A):155-160. PubMed ID: 26956629 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs. Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724 [TBL] [Abstract][Full Text] [Related]
18. Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy. Stöhr T; Kupferberg HJ; Stables JP; Choi D; Harris RH; Kohn H; Walton N; White HS Epilepsy Res; 2007 May; 74(2-3):147-54. PubMed ID: 17433624 [TBL] [Abstract][Full Text] [Related]
19. Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases. Takada M; Fujimoto M; Motomura H; Hosomi K Int J Med Sci; 2016; 13(1):48-59. PubMed ID: 26816494 [TBL] [Abstract][Full Text] [Related]
20. Effects of the novel antiepileptic drug lacosamide on the development of amygdala kindling in rats. Brandt C; Heile A; Potschka H; Stoehr T; Löscher W Epilepsia; 2006 Nov; 47(11):1803-9. PubMed ID: 17116018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]